Abstract
Introduction: Lymphocyte radiosensitivity measured by SF2 has been related to outcome after radical radiotherapy for cervical cancer. In routine clinical practice, SF2 estimates are not practicable but peripheral lymphocyte counts are routinely measured. This study seeks to evaluate the predictive value of changes in peripheral lymphocyte count during chemoradiation for cervical cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
